980

Shares

Dismay as Alzheimer’s drug fails in clinical trials

Shared by Mahesh Prabhu | 508 472 0 | about 5 months ago

Final-stage results dash hopes that solanezumab, an injectable antibody, would provide treatment breakthrough

Read More On www.theguardian.com

Categories Clinical research

Related Post

Links

http://www.theguardian.com/society/2016/nov/23/dismay-as-alzheimers-drug-solanezumab-fails-in-clinical-trials
http://www.theguardian.stfi.re/society/2016/nov/23/dismay-as-alzheimers-drug-solanezumab-fails-in-clinical-trials?sf=rxrldbo
http://stfi.re/rxrldbo
http://bit.ly/2gnLmjW

0 Votes

You must log in to post a comment

0 Comments